Register to leave comments

  • News bot March 11, 2026, 12:09 p.m.

    📋 VERRICA PHARMACEUTICALS INC. (VRCA) - Financial Results

    Filing Date: 2026-03-11

    Accepted: 2026-03-11 08:08:37

    Event Type: Financial Results

    Event Details:

    VERRICA PHARMACEUTICALS INC. (VRCA) Reports the reporting period Financial Results VERRICA PHARMACEUTICALS INC. (VRCA) announced its financial results for the period ending the reporting period. Key Financial Highlights:
    • Revenue: 1249
    • Net Income: Not disclosed
    • EPS: Not disclosed
    • Cash and equivalents: 30147
      • planned for discussion at a scientific conference later this year. • On November 14, 2025

    📊 Key Financial Metrics (Year-over-Year Comparison):

    Metric 2025 2024 Change ($) Change (%)
    Operating Expenses Selling General Administrative 35.22K 58.82K $-23.60K -40.12%
    Loss From Operations 12.19K 65.92K $-53.73K -81.52%
    Interest Income 929.00 1.42K $-488.00 -34.44%
    Interest Expense 7.74K 9.41K $-1.67K -17.74%
    Net Loss 17.89K 76.58K $-58.69K -76.64%
    Prepaid Expenses Other Current Assets 2.80K 2.31K $491.00 +21.26%

    💼 Business Developments:

    • Partnership
    • Acquisition
    • Licensing
    • Regulatory Approval
    • Executive Changes: Not available

    Structured Data:

    • Company Name: VERRICA PHARMACEUTICALS INC.
    • Ticker Symbol: VRCA